Lineweaver Wealth Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,270
Closed -$260K 142
2022
Q1
$260K Sell
4,270
-277
-6% -$16.5K 0.07% 120
2021
Q4
$299K Sell
4,547
-57
-1% -$3.65K 0.09% 108
2021
Q3
$289K Sell
4,604
-280
-6% -$17.9K 0.09% 112
2021
Q2
$293K Sell
4,884
-53,070
-92% -$3.07M 0.1% 101
2021
Q1
$3.19M Sell
57,954
-23,658
-29% -$1.31M 1.13% 21
2020
Q4
$4.45M Sell
81,612
-1,212
-1% -$63.4K 1.75% 21
2020
Q3
$4.14M Buy
82,824
+768
+0.9% +$37.2K 1.85% 19
2020
Q2
$3.62M Buy
+82,056
New +$3.51M 1.84% 19

Other funds holding IHI

Lineweaver Wealth Advisors's IHI Position: Q2 2022 in Review

Lineweaver Wealth Advisors sold out of iShares US Medical Devices ETF (IHI) in Q2 2022, closing a stake of 4,270 shares — an estimated $260K sold.

Lineweaver Wealth Advisors first reported a position in IHI in Q2 2020 and held it in 8 quarters. The position peaked at $4.45M in Q4 2020. 592 funds tracked by Wall St. Rank hold IHI as of Q2 2022.

  • Lineweaver Wealth Advisors reported no remaining iShares US Medical Devices ETF position as of Q2 2022 after selling out during the quarter.
  • Lineweaver Wealth Advisors sold 4,270 iShares US Medical Devices ETF shares in Q2 2022, an estimated $260K.
  • Lineweaver Wealth Advisors first reported a position in iShares US Medical Devices ETF in Q2 2020 and held it in 8 quarters.
  • Lineweaver Wealth Advisors's iShares US Medical Devices ETF position peaked at $4.45M in Q4 2020.
  • 592 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2022.

Based on Lineweaver Wealth Advisors's 13F filing for Q2 2022, filed 26 Jul 2022.